• 09 Feb 26
 

Warpaint London PLC - Acquisition of Barry M brand & FY25 Trading Update


Warpaint London PLC | W7L | 222 2.5 1.1% | Mkt Cap: 179.8m



RNS Number : 1342S
Warpaint London PLC
09 February 2026
 
9 February 2026

 

Warpaint London PLC

 

("Warpaint", the "Company" or the "Group")

 

Acquisition of Barry M brand and FY25 Trading Update

 

 

Warpaint London plc (AIM: W7L; OTCQX: WPNTF), the specialist supplier of colour cosmetics and owner of the W7, Technic, Skin & Tan, Super Facialist, Dirty Works and Fish Soho brands announces the acquisition of the Barry M brand, along with providing a trading update for the year ended 31 December 2025 ("FY25").

 

Acquisition of the Barry M brand

 

The Group is pleased to announce, subject to court approval expected later today, the acquisition of the Barry M brand, including its IP, stock and order book, but excluding the manufacturing capabilities and any liabilities, out of administration, for a cash consideration of £1.4 million.

 

Barry M is a well-established value cosmetics brand, trading in a similar market segment to Warpaint's cosmetics brands. It also has significant retail distribution channels with one metre plus stands in more than 1,300 stores, including Superdrug (650), Boots (420), Sainsbury's (120), Tesco (50) and Priceline Australia (90), as well as trading direct to consumers online. Barry M had approximately £15 million of revenue in the year ended 28 February 2025. The acquisition is being financed from Warpaint's existing cash resources. The Group has a strong balance sheet with cash balances of £18 million as at 31 January 2026 (31 January 2025: £9 million).

 

FY25 Trading Update

 

Warpaint's revenue for FY25 is expected to be approximately £105 million (2024: £102 million), at an improved gross margin, including a contribution of £12 million from Brand Architekts. The Group successfully delivered its expected strong second half rollout programme into new retail outlets, including with Superdrug, Tesco, Boots, Tigota, Etos and CVS. However, as outlined in the Company's interim results announced on 10 September 2025 revenue was negatively impacted by the closure of Bodycare (-£3 million), a significant customer to Technic, the challenging consumer and customer environment (-£4 million), and business lost as a result of US tariff uncertainty earlier in the year leading to stalled momentum in the US (-£2 million).

 

Group Adjusted EBITDA* for FY25 is expected to be approximately £22 million (2024: £25 million), impacted by the factors outlined above. The Brand Architekt business generated a positive Adjusted EBITDA* contribution of £0.8 million in FY25 (2024: approximate £1 million loss), having been successfully integrated into the Group since its acquisition in February 2025, enabling improved sourcing of product and delivering the expected year one synergies.

 

The Company expects to release its results for the year ended 31 December 2025 in late April 2026.

 

Commenting, Sam Bazini, Chief Executive Officer of Warpaint, said: "Looking ahead to the new year, we expect to see a return to organic growth across the Group and also expect to be able to update the market on further significant new customer roll outs with our full year results in April. In addition, we are delighted to announce today the acquisition of the Barry M brand, which is expected to accelerate our penetration into key UK retail channels.

 

"Despite the 2025 results being heavily impacted by the very challenging macroeconomic environment seen during the year, we were pleased with the progress made in many areas of the Group. In particular with the Brand Architekts business, which delivered a profit in year one and we look forward to developing the further opportunities we see for this business. Across the Group, we remain very well positioned for the future, with a focus on achieving additional improvements in margins and further roll-outs to new retail outlets."

 

Note: All figures used in this announcement, other than those in respect of the financial year ended 31 December 2024, remain subject to audit.

 

* Adjusted for foreign exchange movements, share-based payments and acquisition-related expenses.

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

 

Enquiries:

 

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

c/o IFC

 

 

 

 

 

Shore Capital (Nominated Adviser & Joint Broker)

Patrick Castle, Daniel Bush, Lucy Bowden - Corporate Advisory

Fiona Conroy - Corporate Broking

 

020 7408 4090

Berenberg (Joint Broker)

Clayton Bush, Alix Mecklenburg-Solodkoff, Alex Wright

020 3207 7800

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Staton

 

020 3934 6632

 






 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in theUK primarily to major retailers and internationally to local distributors or retail chains. The Technic brand is sold in theUK and continentalEurope with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition,Warpaint supplies cosmetics under its other brand names of Man'stuff, Body Collection and Chit Chat, each targeting a different demographic. Additionally, inFebruary 2025,Warpaint acquired a number of leading health, beauty and personal care brands that complement its existing cosmetics brands, including Skin & Tan, Super Facialist, Dirty Works and Fish Soho.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPAKEFKKEFA